(Circulation. 1995;92:405-412.)
© 1995 American Heart Association, Inc.
Articles |
Magnesium Cardioplegia Enhances mRNA Levels and the Maximal Velocity of Cytochrome Oxidase I in the Senescent Myocardium During Global Ischemia
Presented at the 67th Scientific Sessions of the American Heart Association, Nov 14-17, 1994, Dallas, Tex.
From the Division of Cardiothoracic Surgery and the Department of Pathology, New England Deaconess Hospital and Harvard Medical School, Boston, Mass.
Correspondence to Sidney Levitsky, MD, Division of Cardiothoracic Surgery, New England Deaconess Hospital, 110 Francis St, Suite 2C, Boston, MA 02215.
 |
Abstract |
|---|
 Top Abstract IntroductionMethods Results Discussion References |
|---|
Background The aged myocardium accumulates significantly more cytosolic calcium [Ca2+]i during ischemia, and functional recovery is more severely compromised as compared with the mature heart. Cardioplegia ameliorates these phenomena. The mechanism by which increased calcium accumulation reduces functional recovery in the senescent myocardium is unknown, but it has been suggested that futile calcium cycling in the mitochondria leading to depletion of ATP stores during normothermic global ischemia may be involved.
Methods and Results To investigate the effect of cardioplegia on mitochondrial calcium ([Ca2+]mt) accumulation and the expression of cytochrome oxidase I (COX I) during global ischemia, mitochondria were isolated from mature (age, 15 to 20 weeks) and aged (age >130 weeks) rabbit hearts after Langendorff perfusion. Five perfused heart groups were investigated: 30 minutes of global ischemia without treatment (control), with potassium (K, 20 mmol/L), magnesium (Mg, 20 mmol/L), or potassium and magnesium (K/Mg) cardioplegia. No significant difference in [Ca2+]mt was evident in mature hearts with any protocol. In aged hearts, [Ca2+]mt was increased in global ischemia but was ameliorated with Mg and K/Mg cardioplegia. COX I mRNA levels in aged hearts were lower in both control and global ischemia but were increased with cardioplegia. Maximal velocities for COX I were significantly increased with Mg cardioplegia both in the mature and the aged myocardium.
Conclusions K and/or Mg cardioplegia ameliorates [Ca2+]mt accumulation in aged hearts during normothermic global ischemia and increases COX I mRNA levels to a level not significantly different from that found in mature hearts.
Key Words: cardioplegia • calcium • aging
|
Introduction |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
We have shown previously that in the isolated perfused rabbit heart, the induction of warm global ischemia results in the rapid accumulation of ([Ca2+]i) and precedes the onset of ischemic contracture.1 2 The aged (<135 weeks) heart was shown to accumulate 30% more [Ca2+]i during 30 minutes of normothermic global ischemia than the mature heart (age, 15 to 20 weeks).3 4 5 We also have shown that increased [Ca2+]i during ischemia was correlated with reduced functional recovery of the myocardium and that these functional decrements were amplified in the aged heart as compared with the mature heart.3 4 5 The mechanism(s) contributing to this age-related injury have yet to be elucidated; however, the regulation of cellular calcium transport and high-energy phosphate preservation have been postulated to play a central role in determination of myocardial ischemic injury.6 7 8 9
Myocardial tissue is primarily aerobic, and its metabolism is closely dependent on oxygen, as confirmed by the abundance of mitochondria (30% of the total volume). The high energy requirement of the myocardium is almost exclusively met by mitochondrial oxidative phosphorylation.10 This leads to a high sensitivity of the myocardial cell to oxygen deficiency, and mitochondrial function is likely to play a central role in the molecular events leading to tissue damage occurring under the condition of ischemia.11 One mechanism that may contribute to the reduction of ischemic tolerance in the senescent myocardium may relate to the observed alterations in calcium homeostasis in the aging mitochondria.10 12 13 Previous studies in adult rat heart have indicated that an increase in [Ca2+]i precedes lethal myocardial injury and that this increase is associated with the depletion of cellular ATP.7 Investigation of myocardial energy metabolism with aging in intact hearts and isolated mitochondria have shown that maximal myocardial substrate oxidation rates decline approximately 20% from the mature heart to the senescent heart in the rat.14 In addition, studies in isolated mitochondria have shown that aging is associated with reduced oxidation rates.15 16 These data suggest that during ischemia and reperfusion, myocardial high-energy phosphate preservation may be compromised in the aged as compared with the mature heart.
The mechanism of action of increased calcium accumulation in reducing functional recovery in the senescent myocardium is unknown at present, but it is reasonable to suggest that futile calcium cycling in the mitochondria leading to depletion of ATP stores during normothermic global ischemia would have a deleterious effect on the myocyte.10 17 18 19 Recently we have shown that the use of magnesium-supplemented potassium cardioplegia preserves high-energy phosphates best in the aged heart. The mechanism of action of this cardioplegic protection remains to be elucidated.20
One enzyme that may be an indicator of impaired mitochondrial function is COX. COX is the terminal enzyme complex of the inner mitochondrial electron transport chain and has been shown to be vital in the production of high-energy phosphate.10 The activity of cytochrome oxidase has been shown to sharply decline in the latter part of life and may compromise high-energy phosphate preservation in the aged.21
We have shown previously that magnesium-supplemented potassium cardioplegia modulates [Ca2+]i in aged hearts during 30-minute normothermic global ischemia and enhances myocardial functional recovery.2 4 5 The mechanism of action of magnesium-supplemented potassium cardioplegia may involve modulation of mitochondrial functiona through the amelioration of [Ca2+]mt accumulation. In this report, we show that magnesium-supplemented potassium cardioplegia ameliorates [Ca2+]mt accumulation during normothermic global ischemia in the senescent myocardium and enhances COX I, Vmax, and mRNA levels. With the increased incidence of elderly patients as candidates for complex cardiac surgery, these findings may have important implications for reducing morbidity and mortality during cardiac surgery.
|
Methods |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
New Zealand White rabbits aged 15 to 20 weeks (mature, n=60) and >130 weeks (aged, n=60) were obtained from Millbrook Farm, Amherst, Mass. All animals were housed individually and provided with laboratory chow and water ad libitum. All experiments were approved by the New England Deaconess Hospital Animal Care and Use Committee and conformed to the US National Institutes of Health guidelines regulating the care and use of laboratory animals. All chemicals used were of electrophoresis grade or ultrapure quality.
Surgical Preparation and Perfusion
All rabbits were
anesthetized with sodium pentobarbital
(Nembutal, 100 mg/kg IV) and heparin (200 U/kg IV). The heart was
excised and placed in a 4°C bath of Krebs-Ringer solution containing
(mmol/L) NaCl 100, KCl 4.7, CaCl2 1.7, MgSO4
1.2, NaHCO3 25, KH2PO4 1.1, glucose
11.5, sodium pyruvate 4.9, and sodium fumarate 5.4 equilibrated with
95% O2 and 5% CO2 (pH 7.4 at 37°C), in
which spontaneous beating ceased within a few seconds. Polyethylene
cannulas were advanced into the main pulmonary artery, the
right superior vena cava, and the left atrium via the pulmonary
vein, respectively, and held in place by sutures. The
inferior and left superior vena cavae were closed near
their insertion into the right atrium, and the left atrium was opened.
A latex balloon containing a catheter-tipped transducer (Millar
Instruments, Inc) was inserted into the left ventricle and held in
place by a purse-string suture. The volume of the water-filled
balloon was maintained at a constant physiological
end-diastolic pressure in a range of 5 to 10 mm Hg with
use of a calibrated microsyringe. The aorta was cannulated with a metal
cannula, and the heart was subjected to Langendorff retrograde
perfusion at a constant pressure of 75 cm H2O at 37°C.
Left ventricular pressure was recorded, and an ECG was
obtained with electrodes placed on the epicardial surface of the right
ventricle to monitor equilibrium. The heart was placed in the
water-jacketed chamber, and myocardial temperature was maintained
at 37°C. After 30 minutes of Langendorff retrograde circulation for
equilibrium, the hearts were used in the following protocols.
Measurement of
[Ca2+]i
Accumulation
The fluorescent calcium indicator fura-2 was used to
measure quantitatively the [Ca2+]i
accumulation. After 30 minutes of Langendorff retrograde circulation
for equilibrium, background fluorescence and
hemodynamic data of left ventricular
pressure were recorded as control data. The heart then was loaded
with 2.5 µmol/L fura-2 in Krebs-Ringer solution and recirculated for
15 minutes. After the loading process, the heart was perfused for 30
minutes with Krebs-Ringer solution to wash out unincorporated fura-2
AM. All of the effluent from the myocardium, including the
fluorescent dye solution, was drained through the cannulas in
order to keep the surface of the heart dry during the experiment.
Fura-2 epifluorescence (510 nm) from the epicardial surface
of the left ventricle was measured using an in-house
spectrofluorescence system that supplied rapidly
alternating excitation wavelengths (340 nm, 380 nm) to the isolated
perfused heart and allowed for the quantitative determination of
[Ca2+]i from the ratio of emission
induced by the two excitation
wavelengths.4 5 22 The
fura-2 fluorescence ratio was calculated as previously
described.4 5 22
Cardioplegia
The effects of cardioplegia on
[Ca2+]i during 30 minutes of
normothermic global ischemia were investigated in
four cardioplegic groups for both mature and aged hearts. After 30
minutes of equilibrium perfusion, normothermic global
ischemia was achieved by clamping the ascending aorta for 30
minutes. Tissue temperature was maintained at 37°C throughout the
experimental protocols. The four cardioplegic groups investigated were
(1) hearts subjected to ischemia without cardioplegia (global),
(2) hearts subjected to ischemia after potassium cardioplegia
(K, 20 mmol/L KCl), (3) hearts subjected to ischemia after
magnesium cardioplegia (Mg, 20 mmol/L MgSO4), and (4)
hearts subjected to ischemia after a combination of potassium
and magnesium cardioplegia (K/Mg, 20 mmol/L each KCl and
MgSO4). Cardioplegic solutions were perfused at a constant
pressure of 75 cm H2O at 37°C for 5 minutes before the
onset of ischemia. Control hearts were perfused for 65 minutes
with Krebs-Ringer solution at a constant pressure of 75 cm
H2O at 37°C. The hearts were rapidly frozen in liquid
nitrogen; experimental protocols were followed to allow for subsequent
determinations.
Comparison of Wet and Dry Weights
Frozen samples from all
experimental groups were weighed (wet
weight) and dried at 80°C for 24 hours for reweighing (dry weight)
and then were used for the determination of wet/dry weight ratios,
using previously described methods.4 5
Isolation of Mitochondria
Mitochondria were isolated by
differential
centrifugation according to the method of Welter et
al.23 All procedures were performed at 4°C unless
otherwise stated. Mitochondria were isolated under conditions that
favored retention of endogenous calcium and magnesium,
without the use of albumin or EDTA.24
Determination of
[Ca2+]mt
Mitochondrial pellets
were suspended in 1% hydrochloric acid
and sonicated with the use of an ultrasonic homogenizer
(36260 series, Cole-Palmer). Quantitative colorimetric
determinations were carried out with the use of
o-cresolphthalein complexone.25
Isolation of mtDNA
mtDNA was isolated according to the method
of Welter et
al.23 mtDNA concentration was determined by method
according to Burton.26
Determination of Mitochondrial Magnesium
Mitochondrial
magnesium content was determined by sonication,
followed by quantitative colorimetric assay with use of
the calmagnite reaction.27
Determination of COX Vmax and Km
Cytochrome oxidase activity was determined by methods described
by Sohal.28 The decrease in absorbance at 550 nm was
monitored for 10 minutes. Values were recorded and calculated at
1-minute intervals by the Ultrospec II (LKB) fitted with the
ENZYME KINETICS software package (Pharmacia).
Isolation of RNA: Northern Hybridization
Total cellular RNA
was isolated by the method of Chomzynski and
Sacchi29 and fractionated on a 1% agarose gel containing
3% formaldehyde, 0.02 mol/L MOPS, pH 7.4,
(3-[N-morpholino] propanesulfonic acid, and 0.001 mol/L
disodium EDTA.30 The RNA was visualized by ethidium
bromide staining and then was transferred to nitrocellulose overnight
with 10x SSC (pH 7.0). COX I mRNA levels were detected
using a 1-kb, EcoRI insert from the human COX I clone
(American Type Culture Collection, ATCC). ATP synthase mRNA levels were
detected using a 1.6-kb, EcoRI insert from the human ATP
synthase clone (ATCC). The 2.0-kb insert from the ß-actin
"housekeeping gene" cDNA (Clontech Laboratories) was used as a
control. Each probe, COX I, ATPsynthase, and ß-actin, was
successively hybridized on the same nitrocellulose membrane to detect
transcripts. This sequence was repeated on four separate membranes
(n=4). Isolated and purified cDNA fragments were labeled with
32Pd-ATP according to the method described by Feinberg and
Vogelstein.31 Free nucleotides were removed by
Sephadex G-50 (Pharmacia) column
chromatography.32
Semiquantitative Analysis
Semiquantitative analysis of
autoradiographies was
performed with the use of an LKB Ultrascan XL laser densitometer
(Pharmacia LKB). The integral for each blot was calculated with use of
the LKB GelScan XL software program for one-dimensional
analysis.
Statistical Analysis
Statistical analysis was performed using
the
STATVIEW II software package. All results are
presented as mean±SEM. Experimental differences were
determined by a one-way ANOVA and the Scheffé test.
Significance is claimed whenever the confidence level is greater than
95% (P<.05).
|
Results |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
Effects of Cardioplegia on Dry Weight/Wet Weight Ratios After 30 Minutes of Normothermic Global Ischemia in the Mature and Aged Myocardium
The effects of cardioplegia on dry weight/wet weight ratios after 30 minutes of normothermic global ischemia in the mature and aged myocardium are shown in Table 1
. No significant
difference in dry weight/wet ratios
was found between mature and aged hearts with any cardioplegic
treatment groups when compared with controls.
|
mtDNA Concentration
To allow for standardization of results
and to account for
possible differences in mitochondrial populations in the mature and
aged heart, mtDNA concentration per gram wet weight was
measured.36 Our results (Table 2) indicate that
mtDNA concentrations per
gram wet weight were not statistically different between mature and
aged hearts in control and that no significant change in mtDNA
concentration occurred as the result of perfusion with or without
cardioplegia. These results allowed for the use of mtDNA to provide a
basis for the comparison of intraorganelle cation concentration.
|
Effects of Cardioplegia on Mitochondrial Magnesium Accumulation
After 30 Minutes of Normothermic Global Ischemia in
the Mature and Aged Myocardium
To ensure that observed differences in
[Ca2+]mt were not the result of
differences in mitochondrial magnesium uptake,
[Mg2+]mt in mitochondrial pellets was
determined. Our results shown in Table 3 indicate that
[Mg2+]mt expressed as micromoles per
liter per milligram of mtDNA was not significantly different between
mature and aged hearts in control and were not altered by cardioplegic
treatment when compared with controls.
|
Effects of Cardioplegia on
[Ca2+]i
and [Ca2+]mt Accumulation After 30
Minutes of Normothermic Global Ischemia in the
Mature and Aged Myocardium
The effects of cardioplegia on
[Ca2+]i and
[Ca2+]mt during 30 minutes of
normothermic global ischemia in the mature and aged
myocardium are illustrated in Figs 1 and 2.
Ca2+]i
was significantly increased (P<.05) from 178.7±26.5 to
393.6±28.0 nmol/L in mature hearts subjected to
normothermic global ischemia without cardioplegia
(global) as compared with preischemic (Cont, Fig 1). The
use of K cardioplegia reduced [Ca2+]i
accumulation to 300.9±10.6 nmol/L (P<.05), but Mg or K/Mg
cardioplegia was found to completely inhibit
[Ca2+]i accumulation (198.7±25.4
and
182.3±21.1 nmol/L, respectively; P<.05). No significant
difference in [Ca2+]i accumulation was
found between Mg and/or K/Mg cardioplegia.
|
|
[Ca2+]mt accumulation expressed as
the
percent increase above control during 30 minutes of
normothermic global ischemia in the mature
myocardium also is illustrated in Fig 1
. No
significant difference in [Ca2+]mt
accumulation was found to occur in the mature heart during 30 minutes
of normothermic global ischemia with or without the
use of cardioplegia. No difference in
[Ca2+]i was found between mature
(178.7±26.5 nmol/L) and aged (207.0±28.7 nmol/L) hearts during
the
preischemic perfusion period. In aged hearts (Fig 2) subjected
to normothermic global
ischemia without cardioplegia (global),
[Ca2+]i accumulation was increased to
501.0±50.5 nmol/L (P<.05), a level approximately 30%
above that observed in mature hearts (P<.05). The use of K
cardioplegia reduced [Ca2+]i
accumulation to approximately 75% of that obtained in hearts subjected
to ischemia without cardioplegia in aged hearts
(365.2±27.7 nmol/L, P<.05), whereas Mg or K/Mg
cardioplegia was found to attenuate
[Ca2+]i accumulation (261.3±26.7
and
262.3±25.2 nmol/L, respectively; P<.05). No significant
difference in [Ca2+]i accumulation was
found between Mg and/or K/Mg cardioplegia.
[Ca2+]mt accumulation during 30
minutes of normothermic global ischemia in the aged
heart (Fig 2) was significantly increased above control
in global ischemia (166%, P<.05) and with K
cardioplegia (143%, P<.05). The use of Mg and K/Mg
cardioplegia ameliorated these effects. No significant difference in
[Ca2+]mt accumulation was found
between Mg and/or K/Mg cardioplegia.
Effects of Cardioplegia on COX I mRNA Levels After 30 Minutes of
Normothermic Global Ischemia in the Mature and
Aged Myocardium
A representative Northern blot showing the effect
of cardioplegia on COX I mRNA levels after 30 minutes of
normothermic global ischemia in the mature and aged
myocardium is shown in Fig 3.
Analysis with the use of scanning laser densitometry (Fig 4)
indicated that mRNA levels of COX I
remained unchanged in all mature protocols (control,
normothermic global ischemia, or
normothermic global ischemia treated with high [20
mmol/L] K cardioplegia, high [20 mmol/L] Mg cardioplegia, or
high
K/Mg cardioplegia).
|
|
In the aged myocardium, COX I mRNA levels were found to be significantly decreased (P<.05) in both control and global ischemia, with mRNA levels only approximately 50% that found in mature hearts (0.183±0.028 versus 0.364±0.029 arbitrary units in control for aged and mature, respectively) and after 30 minutes of normothermic global ischemia (0.178±0.019 versus 0.423±0.013 arbitrary units, P<.05 for aged and mature, respectively). The use of cardioplegia was found to increase COX I mRNA levels significantly such that there was no significant difference between mature and aged hearts. No significant difference between cardioplegic treatments was observed. COX I mRNA levels remained elevated in aged hearts after 30 minutes of normothermic reperfusion (results not shown).
No difference in ATP synthase mRNA
levels was found between mature and
aged hearts or with any cardioplegic treatment (results not
shown). No difference in ß-actin mRNA levels was found between
mature and aged hearts or with any cardioplegic treatment (Fig
3).
Effects of Cardioplegia on COX Vmax After 30 Minutes of
Normothermic Global Ischemia in the Mature and
Aged Myocardium
The effects of cardioplegia on COX Vmax
after 30
minutes of normothermic global ischemia in the
mature and aged myocardium are shown in Fig 5. No significant
difference in COX Vmax
(micromoles per liter of cytochrome c oxidized per minute)
was found between mature and aged hearts in control. In mature hearts
COX Vmax was significantly increased above global with Mg
cardioplegia. COX Vmax in global ischemia, K
cardioplegia, and K/Mg cardioplegia in mature hearts was not
significantly different from control.
|
In aged hearts after 30 minutes of normothermic global ischemia, COX Vmax was found to be significantly decreased (P<.05) but was significantly increased above global (P<.05) with Mg cardioplegia. K and K/Mg cardioplegia increased COX Vmax above that found in global ischemia and were not significantly different from control.
|
Discussion |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
Ischemia has been shown to increase [Ca2+]mt accumulation, resulting in decreased mitochondrial cytochrome and respiratory activity.17 Increased [Ca2+]mt accumulation destabilizes the inner mitochondrial membrane and causes the inner membrane pore to open, permitting further movement of cations across the mitochondrial membrane.10 The opening of these pores renders the mitochondrion incapable of making ATP and has been suggested as a key event in the process leading to myocardial cell death.33 In previous reports, we have shown that in the isolated perfused rabbit heart, the induction of warm global ischemia results in the rapid accumulation of [Ca2+]i and precedes the onset of ischemic contracture.1 34 In a series of experiments using newborn (age, 3 to 5 days) and adult (age, 4 to 5 months) rabbit hearts, an age-related susceptibility to ischemia/reperfusion injury was observed.3 35 When challenged with 30 minutes of warm global ischemia followed by 30 minutes of normothermic reperfusion, newborn hearts returned rapidly to preischemic cardiac function, and myocardial high-energy phosphate stores were restored. In the adult hearts subjected to the same protocol, functional recovery was significantly delayed, and the recovery of high-energy phosphate stores was much slower in returning to preischemic levels.36 These age-related differences in functional recovery were correlated with lower [Ca2+]i accumulation during ischemia in the newborn as compared with the adult myocardium.35
In this report, we show that 30 minutes of normothermic
global ischemia results in the rapid accumulation of
[Ca2+]i. In mature hearts, increased
[Ca2+]i was not associated with
increased [Ca2+]mt (Fig
1). In the aged heart, increased
[Ca2+]i was associated with increased
[Ca2+]mt (Fig 2). The
use of Mg or Mg/K cardioplegia modulated
[Ca2+]mt accumulation such that no
significant difference in [Ca2+]mt was
found between mature and aged hearts after 30 minutes of
normothermic global ischemia (Figs 1 and 2).
These
data would indicate that in the aged heart,
[Ca2+]mt accumulation is altered to a
greater degree than in the mature heart. The use of cardioplegia in the
aged heart would appear to ameliorate the age-related differences
in [Ca2+]mt accumulation.
Several lines of evidence indicate that mitochondrial efficiency decreases with age. In the kidney, ischemia and reperfusion have been shown to damage mitochondrial structure and impair respiratory function after 45 minutes of renal ischemia.17 The investigators reported that reperfusion was associated with altered mitochondrial mRNA expression and speculated that enhanced mitochondrial mRNA expression would aid in renal recovery from 45 minutes of ischemia.17 Nishimura et al37 have shown that in the isolated perfused rat heart, the effect of anoxia followed by reoxygenation in isolated mitochondria induced mitochondrial enzyme release and that the magnitude of the release was dependent on the duration of the anoxic period and the concentration of cytosolic ATP. Nohl et al19 have shown that in isolated heart mitochondria treated with ischemia and reperfusion, there was incomplete collapse of the transmembrane proton gradient and the impairment of respiration-linked ATP generation. Our results reported previously20 and those reported herein would agree with these findings and suggest that the use of Mg and/or Mg-supplemented cardioplegia may act to ameliorate these age-related phenomena associated with reduced functional recovery after surgically induced ischemia in the aged heart.
Previous investigators have reported that magnesium included in K cardioplegia (St Thomas' Hospital) was beneficial to coronary flow and aided in the reduction of myocardial enzymatic leakage in the ischemic and reperfused heart.38 Tosaki et al39 also have shown that by increasing extracellular magnesium, there is a reduction in reperfusion-induced ventricular fibrillation and ventricular tachycardia in rat hearts. Recently, Steenbergen et al7 have examined the relationship between ATP depletion, [Ca2+]i concentration, and lethal myocardial ischemic injury in the perfused rat heart with the use of nuclear magnetic resonance and reported that high magnesium (16 mmol/L) arrest delayed [Ca2+]i accumulation and ATP depletion longer than high potassium (30 mmol/L) arrest during normothermic ischemia in the mature rat heart.
High-energy phosphates are required for the proper maintenance of the heart as an aerobic organ. Under normal (nonischemic) conditions, calcium transport from the myocyte during diastole occurs against an electrochemical gradient requiring the use of ATP-dependent calcium transport mechanisms.6 36 The induction of normothermic global ischemia has been shown to rapidly reduce cellular high-energy phosphates. This reduction occurs in the ischemic myocardium through the continuance of a number of reactions that persist during ischemia and include the energy-dependent cellular transport mechanisms and enzymatic reactions.6 36 Previous investigation has shown that rabbit hearts subjected to normothermic global ischemia are rapidly depleted of ATP tissue stores and that the accumulation of [Ca2+]i is associated with or precedes the changes in cellular high-energy phosphates.40
In the myocardium, magnesium has been shown to act as a physiological calcium blocker as well as being required as an essential cofactor complexed to ATP and other adenine nucleotides for energy transfer reactions.41 42 It also has been shown that high magnesium concentrations in the extracellular space inhibit calcium entry into the cell by displacing calcium from its binding sites in the sarcolemmal membrane.43
The mechanism of action of Mg-supplemented cardioplegia remains to be described, but one possibility for this cardioprotection is the inhibitory action of magnesium. To date, ruthenium red and magnesium are the only two reported agents to block calcium influx via the mitochondrial uniporter.44 Benzi and Lerch45 have shown that postischemic perfusion with ruthenium red, a hexavalent dye that inhibits [Ca2+]mt uptake, significantly decreased oxygen consumption in the ischemic heart and enhanced contractile function.
It has been speculated that mitochondrial "futile calcium cycling," an energy-dependent process requiring ATP to transport calcium against the electrochemical gradient out of the mitochondrion, utilizes needed ATP required by the ischemic cell for more necessary functions and that inhibition of this process would be of benefit to myocardial functional recovery.24
The mechanism leading to increased [Ca2+]mt accumulation in the aged as compared with the mature myocardium is unknown; however, it may be speculated that alterations in mitochondrial oxidative capacity may account for at least part of the difference observed. Previous investigators have reported an age-related decline in mitochondrial energy production, possibly as a result of decreased repair or resynthesis of mitochondrial enzymes.46 Gadeleta et al have shown in the senescent rat heart (and brain) that while mtDNA copy number per cell remains stable, there is a reduced steady state level of mtDNA transcripts compared with the adult rat and that this decrease is due to reduced mitochondrial RNA synthesis in the aged rat heart. It is reasonable to speculate that increased [Ca2+]mt accumulation in the aged heart may be a consequence of the reduced synthesis of mitochondrial enzymes required for maintenance of [Ca2+]mt homeostasis.
Support for this hypothesis may be seen in the response of COX
Vmax to global ischemia. Our results indicate that
COX Vmax in mature and aged hearts is not significantly
different at control (preischemia), but, after 30-minute
global ischemia, COX Vmax in aged hearts is
decreased significantly as compared with mature hearts (Fig 5).
Our data also indicate that in the
aged heart, COX I mRNA levels remain decreased as compared with the
mature heart during global ischemia. These results would
support the hypothesis that the mitochondria of the aged heart is
compromised such that resynthesis of oxidative enzymes is attenuated.
The increase in COX I mRNA levels and the associated increase in COX
Vmax with the use of Mg cardioplegia would indicate that
this age-related modulation in mitochondrial response may be
reversible.
Aging in the myocardium would appear, from our data, to
compromise the ability of the mitochondria to regulate calcium
transport during normothermic global ischemia. The
effects of aging and normothermic global ischemia
on the aged myocardium would also appear to decrease
mitochondrial COX I mRNA transcript levels, which possibly would
contribute to the diminishment of high-energy phosphates. Our
results show that the use of cardioplegia increased COX I mRNA levels
in the aged heart to a level not significantly different from that
found in the mature heart (Figs 3 and 4). COX
activity
(Vmax) also was increased with cardioplegia above
that found in global ischemia in the aged heart.
An association between increased [Ca2+]i and [Ca2+]mt accumulation in the aged myocardium appears to exist and is associated with reduced functional recovery in the aged as compared with the mature heart. The use of Mg-supplemented cardioplegia appears to ameliorate these factors and allows for enhanced functional recovery, possibly through improved mitochondrial function. These findings may have important implications in reducing morbidity and mortality during cardiac surgery in the aged heart.
|
Selected Abbreviations and Acronyms |
|---|
|
|
Acknowledgments |
|---|
This study was supported by the National Institutes of Health (HL-29077).
|
References |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
1. Pridjian A, Levitsky S. Intracellular sodium and calcium in the post-ischemic myocardium. Ann Thorac Surg.. 1987;43:416-419. [Abstract]
2. Jimenez E, del Nido P, Sarin M. Effects of low extracellular calcium on cytosolic calcium and ischemic contracture. J Surg Res.. 1990;49:252-255. [Medline] [Order article via Infotrieve]
3. Ataka K, Chen D, Levitsky S. Effect of aging on intracellular Ca2+, pHi, and contractility during ischemia and reperfusion. Circulation. 1992;86(suppl II):II-371-II-376.
4. Tsukube T, McCully JD, Faulk E, Federman M, LoCicero J, Krukenkamp IB, Levitsky S. Warm magnesium cardioplegia reduces cytosolic and nuclear calcium and DNA fragmentation in the senescent myocardium. Ann Thorac Surg.. 1994;58:1005-1011. [Abstract]
5. Ataka K, Chen D, McCully JD, Levitsky S, Feinberg H. Magnesium cardioplegia prevents accumulation of cytosolic calcium in the ischemic myocardium. J Mol Cell Cardiol.. 1993;25:1387-1390.[Medline] [Order article via Infotrieve]
6. Jennings RB, Steenbergen C Jr. Nucleotide metabolism and cellular damage in myocardial ischemia. Annu Rev Physiol.. 1985;47:727-749. [Medline] [Order article via Infotrieve]
7.
Steenbergen C, Murphy E, Watts JA, London RE.
Correlation between cytosolic free calcium, contracture, ATP, and
irreversible ischemic injury in perfused rat heart.
Circ Res.. 1990;66:135-146.
8. Jennings RB, Reimer KA. Lethal myocardial ischemic injury. Am J Pathol.. 1981;102:241-255. [Medline] [Order article via Infotrieve]
9.
Lakatta EG. Cardiovascular
regulatory mechanisms in advanced age. Physiol Rev.. 1993;73:413-467.
10. Frolkis VV, Frolkis RA, Mkhitarian LS, Shevchuk VG, Fraifeld VE, Vakulenko LG, Syrovy I. Contractile function and Ca2+ transport system of myocardium in ageing. Gerontology.. 1988;34:64-74. [Medline] [Order article via Infotrieve]
11. Ferrari R, Pedersini P, Bongrazio M, Gaia G, Bernocchi P, DiLisa F, Visioli O. Mitochondrial energy production and cation control in myocardial ischaemia and reperfusion. Basic Res Cardiol.. 1993;88:495-512. [Medline] [Order article via Infotrieve]
12. Miquel J. An update on the mitochondrial-DNA mutation hypothesis of cell aging. Mutat Res. 1993;275:209-216.
13. Martinez M, Ferrandiz ML, De Juan E, Miquel J. Age-related changes in glutathione and lipid peroxide content in mouse synaptic mitochondria: relationship to cytochrome c oxidase decline. Neurosci Lett.. 1994;170:121-124. [Medline] [Order article via Infotrieve]
14. Abu-Erreish G, Neely J, Whitmer J, Whitman V, Sanadi D. Fatty acid oxidation by isolated perfused working hearts of aged rats. Am J Physiol. 1977;232:E258-E262.
15. Chen J, Warshaw J, Sanadi D. Regulation of mitochondrial respiration in senescence. J Cell Physiol. 1970;80:141-148.
16. Hansford R. Lipid oxidation by heart mitochondria from young adult and senescent rats. Biochem J.. 1978;170:285-295. [Medline] [Order article via Infotrieve]
17.
Van Itallie CM, Van Why S, Thulin G, Kashgarian M,
Siegel NJ. Alterations in mitochondrial RNA expression after
renal ischemia. Am J Physiol (Cell Physiol). 1993;265:C712-C719.
18. Silverman HS. Mitochondrial free calcium regulation in hypoxia and reoxygenation: relation to cellular injury. Basic Res Cardiol.. 1993;88:483-494. [Medline] [Order article via Infotrieve]
19. Nohl H, Koltover V, Stolze K. Ischemia/reperfusion impairs mitochondrial energy conservation and triggers O2 release as a byproduct of respiration. Free Radic Res Commun.. 1993;18:127-137. [Medline] [Order article via Infotrieve]
20. Tsukube T, McCully JD, Federman M, Krukenkamp IB, Levitsky S. Developmental differences in cytosolic calcium accumulation associated with surgically induced global ischemia: optimization of cardioplegic protection and mechanism of action. J Thorac Cardiovasc Surg. In press.
21. Pieri C, Recchioni R, Moroni F. Age-dependent modifications of mitochondrial trans-membrane potential and mass in rat splenic lymphocytes during proliferation. Mech Ageing Dev. 1993;70:201-212. [Medline] [Order article via Infotrieve]
22.
Chen DP, Jimenez E, Ataka K, Levitsky S, Feinberg
H. Fura 2 determination of [Ca2+]i in
isolated perfused heart using R wave-gated electromechanical
shutters. J Appl Physiol.. 1994;76:1394-1399.
23. Welter C, Dooley S, Blin N. A rapid protocol for the purification of mitochondrial DNA suitable for studying restriction fragment length polymorphisms. Gene. 1989;83:169-72. [Medline] [Order article via Infotrieve]
24. Peng CF, Kane JJ, Murphy ML, Straub KD. Abnormal mitochondrial oxidative phosphorylation of ischemic myocardium by Ca2+-chelating agents. J Mol Cell Cardiol. 1977;9:897-908. [Medline] [Order article via Infotrieve]
25. Walmsley TA, Fowler RT. Optimal use of 8-hydroxyquinoline in plasma calcium determinations. Clin Chem. 1981;27:1782. Letter. [Medline] [Order article via Infotrieve]
26. Burton K. DNA determination. Biochem J. 1956;62:315-323. [Medline] [Order article via Infotrieve]
27. Briggs AP. A colorimetric method for the determination of small amounts of magnesium. J Biol Chem.. 1922;47:411-415.
28. Sohal RS. Aging, cytochrome oxidase activity, and hydrogen peroxide release by mitochondria. Free Radic Biol Med.. 1993;14:583-588. [Medline] [Order article via Infotrieve]
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation and acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem.. 1987;162:156-159. [Medline] [Order article via Infotrieve]
30. Lehrach H, Diamond D, Wozney JM, Boedtker H. RNA molecular weight determinations by gel electrophoresis under denaturing conditions: a critical reexamination. Biochemistry. 1977;16:4743-4751. [Medline] [Order article via Infotrieve]
31. Feinberg AP, Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem.. 1987;137:266-267.
32. Maniatis T, Fritsch E, Sambrook J, eds. Molecular Cloning: A Laboratory Manual. New York, NY: Cold Spring Harbor Laboratory; 1982.
33.
McCormack JG, Denton RM. Signal transduction by
intramitochondrial Ca2+ in mammalian energy
metabolism. NIPS.. 1994;9:71-76.
34. Jimenez E, del Nido P, Sarin M. Effects of low extracellular calcium on cytosolic calcium and ischemic contracture. J Surg Res.. 1990;49:252-255.
35. Nakamura H, del Nido P, Jimenez E. Age related differences in cardiac susceptability to ischemia/reperfusion injury: response to deferoxamine. J Thorac Cardiovasc Surg.1992;104:165-172.
36. Myocardial contraction and relaxation. In: Opie LH, ed. The Heart: Physiology and Metabolism. 2nd ed. New York, NY: Raven Press Publishers; 1991:176-194.
37.
Nishimura M, Takami H, Kaneko M, Nakano S, Matsuda H,
Kurosama K, Inoue T, Tagawa K. Mechanism of mitochondrial enzyme
leakage during reoxygenation of the rat
heart. Cardiovasc Res.. 1993;27:1116-1122.
38. Hearse DJ, Garlick PB, Humphrey SM. Ischemic contracture of the myocardium: mechanism and prevention. Am J Cardiol.. 1977;39:986-993. [Medline] [Order article via Infotrieve]
39.
Tosaki A, Szerdahelyi P, Engelman RM, Das DK.
Effects of extracellular magnesium manipulation on
reperfusion-induced arrythmias and myocardial ion shifts in
isolated ischemic reperfused rat hearts. J
Pharmacol Exp Ther.. 1993;267:1045-1053.
40. Nayler W, Panagiotopoulos S, Elz J. Calcium mediated damage during post-ischemic reperfusion. J Mol Cell Cardiol.. 1988;20:41054.
41.
Shine KI. Myocardial effects of
magnesium. Am J Physiol (Heart Circ Physiol).. 1979;237:H413-H423.
42.
Meissner G, Hederson JS. Rapid calcium release
from cardiac sarcoplasmic reticulum vesicles is dependent on calcium
and is modulated by magnesium, adenine nucleotide, and
calmodulin. J Biol Chem.. 1987;262:3065-3073.
43.
Lansman JB, Hess P, Tsien R. Blockade of current
through single calcium channels by Cd2+,
Mg2+, and Ca2+: voltage
and concentration dependence of calcium entry into the pore.
J Gen Physiol. 1986;88:321-347.
44. Denton RM, McCormack JG. Ca2+ as a second messenger within mitochondria of the heart and other tissues. Annu Rev Physiol.. 1990;52:451-466. [Medline] [Order article via Infotrieve]
45.
Benzi RH, Lerch R. Dissociation between
contractile function and oxidative metabolism in
postischemic myocardium. Circ
Res.. 1992;71:567-576.
46.
Peterson C, Goldman JE. Alterations in calcium
content and biochemical processes in cultured skin fibroblasts from
aged and Alzheimer donors. Proc Natl Acad Sci
U S A. 1986;83:2758-2762.
This article has been cited by other articles:
 |
|
 |
|
  J. D. McCully, M. K. Bhasin, C. Daly, M. C. Guerrero, S. Dillon, T. A. Liberman, D. B. Cowan, J. D. Mably, F. X. McGowan, and S. Levitsky Transcriptomic and proteomic analysis of global ischemia and cardioprotection in the rabbit heart Physiol Genomics, July 9, 2009; 38(2): 125 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Rousou, M. Ericsson, M. Federman, S. Levitsky, and J. D. McCully Opening of mitochondrial KATP channels enhances cardioprotection through the modulation of mitochondrial matrix volume, calcium accumulation, and respiration Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1967 - H1976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Levitsky, J. Laurikka, R. D. Stewart, C. T. Campos, S. J. Lahey, and J. D. McCully Mitochondrial DNA deletions in coronary artery bypass grafting patients Eur. J. Cardiothorac. Surg., November 1, 2003; 24(5): 777 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. McCully and S. Levitsky The mitochondrial KATP channel and cardioprotection Ann. Thorac. Surg., February 1, 2003; 75(2): S667 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Toyoda, S. Levitsky, and J. D. McCully Opening of mitochondrial ATP-sensitive potassium channels enhances cardioplegic protection Ann. Thorac. Surg., April 1, 2001; 71(4): 1281 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Toyoda, I. Friehs, R. A. Parker, S. Levitsky, and J. D. McCully Differential role of sarcolemmal and mitochondrial KATP channels in adenosine-enhanced ischemic preconditioning Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2694 - H2703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. B. Krukenkamp and S. Levitsky Myocardial Protection: Modern Studies Ann. Thorac. Surg., May 1, 1996; 61(5): 1581 - 1582. [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||